Regular review of weight loss progress, typically every three months, allows assessment of treatment response and consideration of whether continuation is appropriate according to NICE TA875, which recommends discontinuation if less than 5% weight loss is achieved after six months at the maintenance dose
GLP-1 GIP(glucose-dependent insulinotropic polypeptide) ''
minimally invasive
The surplus TMA precursors that cannot be absorbed are converted by gut bacteria into TMA, which is subsequently oxidised by FMO-1 and FMO-3, produced by the liver, to form TMAO
There was the rapid recruitment of the activated collateral pathways, and the activated upgraded minor vessel becomes capable of substituting the disabled function of the failed major vessel, and reestablishing reorganized blood flow [18,19,20,21,22,23,24,25,26,27,28,29,30]